Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
39 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Takara Bio Inc. (Takara) a subsidiary of Takara Holdings Inc. is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sells gene amplification system. It provides scientific instruments. Takara offers contract research services. The company also produces and sells hatakeshimeji and honshimeji mushrooms. It develops and commercializes medical technologies such as cell and gene therapies for cancer and AIDS. The company supports biotechnology research and bioindustry by offering basic research and drug discovery and development services. Takara is headquartered in Kusatsu, Japan.

Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detail

  
Source:
Document ID
GDPH82157D
Country
Industry
Ticker
4974=JP
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Takara Bio Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Takara Bio Inc., Medical Devices Deals, 2010 to YTD 201691
Takara Bio Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Takara Bio Inc., Pharmaceuticals &Healthcare, Deal Details1224
  Asset Purchase121
    Takara Bio Completes Acquisition Of HF10 Oncolytic Virus Business From M's Science121
  Partnerships131
    Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics132
    Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products151
    Takara Bio Enters Into Research Agreement With TMUCIH161
    Takara Bio Forms Joint Venture With DSS Imagetech171
    NuGEN Enters Into Distribution Agreement With Takara181
    Takara Bio Enters Into Research Agreement With University of Pennsylvania191
  Licensing Agreements201
    MolMed and Takara Bio Terminate Licensing Agreement201
    Cellectis Enters into Licensing Agreement with Takara Bio for RetroNectin211
    Takara Bio Enters into Licensing Agreement with ViaCyte221
    Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System231
    Takara Bio Expands Licensing Agreement With iPS Academia Japan241
    Takara Bio Enters Into Licensing Agreement With Cellular Dynamics International For RetroNectin251
    Eppendorf Enters Into Licensing Agreement With Takara Bio261
    ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs272
    MDxHealth Enters Into Licensing Agreement With Takara Bio291
    Clontech Labs Enters Into Licensing Agreement With TET Systems Holding301
  Equity Offering311
    Takara Bio Prices Public Offering Of Common Stock For US$114.7 Million311
  Acquisition321
    Takara Bio to Acquire WaferGen Bio-Systems322
    Takara Bio Acquires Cellectis, Biotech Company342
Takara Bio Inc. - Key Competitors361
Key Employees371
Locations And Subsidiaries381
  Head Office381
  Other Locations &Subsidiaries381
Appendix391
  Methodology391
  About GlobalData391
  Contact Us391
  Disclaimer391

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Takara-Bio-Inc-4974-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13968>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Takara Bio Inc. (4974) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Takara-Bio-Inc-4974-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13968>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research